Thermo Fisher, A57000PRT, Dynabeads™ CD3 Depletion Prototype

Quantity: 1 Ea.
Unit Size: Each
Features of the Dynabeads CD3 Depletion Reagent Prototype include:
• Effective and consistent depletion of CD3+ T cells using the Dynabeads platform
• Highly pure and viable populations of target CD3- T cells
• Built on the proven Dynabeads magnetic separation platform
• Reliable performance, flexibility, and accessibility needed for process optimizationThe prototype format supports the magnetic labelling CD3+ T cells from a single vial, enabling straightforward process development and optimization of an allogeneic cell therapy workflow.The product will be compatible with the automated large-scale CTS DynaCellect Magnetic Separation System.NotesProduct is a prototype and performance characteristics of this product have not been established.The Product is not yet a commercially released product and is still under development. Any use of the Product is done at the sole risk and discretion of Customer. Additionally, the Customer understands and agrees that the Product is provided 'AS IS' and without warranty of any kind, express, implied or statutory. All warranties are expressly disclaimed, including without limitation, those of merchantability or fitness for a particular purpose, and non-infringement of third-party intellectual property rights, whether arising from statute or in law or from a course of dealing or usage of trade. Life Technologies disclaims all responsibility or liability for Customer's use of the Product (or any portion thereof), including but not limited to any liability or responsibility under Thermo Fisher's standard terms of sale, a negotiated master supply agreement or a quality agreement.For Research Use Only. Not for use in diagnostic procedures. Product is a prototype and performance characteristics of this product have not been established.